平喘止咳方联合西药治疗儿童咳嗽变异性哮喘临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R725.6

基金项目:

台州市社会发展科技计划项目(21ywa52)


Clinical Study on Pingchuan Zhike Prescription Combined with Western Medicine for Children with Cough Variant Asthma
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察自拟平喘止咳方联合硫酸特步他林、布地奈德雾化治疗对儿童咳嗽变异性哮喘(CVA) 的疗效。方法:将120例CVA患儿按随机数字表法分为观察组与对照组各60例。对照组给予硫酸特步他林、 布地奈德雾化治疗,观察组在对照组基础上联合平喘止咳方治疗,2组均治疗14 d。比较2组临床疗效、中医 证候评分、肺功能指标[第1秒用力呼出气体容量(FEV1)、呼气峰流速(PEF) 及肺活量(FVC) ]及免疫球蛋 白E(IgE) 水平、嗜酸性粒细胞计数(EOS)。结果:治疗后,观察组总有效率为96.67%,对照组为85.00%, 2组比较,差异有统计学意义(P<0.05)。治疗后,2组中医证候评分均较治疗前降低(P<0.05),且观察组中 医证候评分低于对照组(P<0.05)。治疗后,2 组肺功能指标FEV1、FVC、PEF 水平均较治疗前上升(P< 0.05),且观察组FEV1、FVC、PEF水平均高于对照组(P<0.05)。治疗后,2组IgE水平、EOS计数均较治疗 前降低(P<0.05),且观察组IgE水平、EOS计数均低于对照组(P<0.05)。结论:平喘止咳方联合硫酸特布 他林、布地奈德雾化治疗CVA患儿可提高临床疗效,有效缓解患儿中医证候,改善肺功能及体液免疫功能, 减轻气道炎症反应。

    Abstract:

    Abstract: Objective: To observe the curative effect of self-made Pingchuan Zhike Prescription combined with Terbutaline Sulfate and Budesonide nebulization treatment on children with cough variant asthma (CVA). Methods:A total of 120 cases of children with CVA were divided into the observation group and the control group according to the random number table method, with 60 cases in each group. The control group was given Terbutaline Sulfate and Budesonide nebulization treatment, and the observation group was additionally treated with Pingchuan Zhike Prescription based on the treatment of the control group. Both groups were treated for 14 days. The clinical effects, traditional Chinese medicine (TCM) syndrome scores, lung function indexes [forced expiratory volume in the first second (FEV1), peak expiratory flow (PEF) and forced vital capacity (FVC)],immunoglobulin E (IgE) levels and eosinophilic (EOS) counts were compared between the two groups. Results: After treatment, the total effective rate was 96.67% in the observation group and 85.00% in the control group, the difference being significant (P< 0.05). After treatment, TCM syndrome scores in the two groups were decreased when compared with those before treatment (P<0.05),and the TCM syndrome score in the observation group was lower than that in the control group (P<0.05). After treatment,the levels of lung function indexes like FEV1,FVC and PEF in the two groups were elevated when compared with those before treatment (P<0.05), and the levels of FEV1,FVC and PEF in the observation group were higher than those in the control group (P<0.05). After treatment, IgE levels and EOS counts in the two groups were reduced when compared with those before treatment (P<0.05),and IgE level and EOS count in the observation group were lower than those in the control group (P<0.05). Conclusion: Pingchuan Zhike Prescription combined with Terbutaline Sulfate and Budesonide nebulization treatment for children with CVA can enhance the clinical effect, effectively relieve the TCM syndromes of children,improve lung function and humoral immune function,and reduce airway inflammation.

    参考文献
    相似文献
    引证文献
引用本文

俞慧君,孙颖,郑亚玲.平喘止咳方联合西药治疗儿童咳嗽变异性哮喘临床研究[J].新中医,2024,56(18):103-107

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2024-09-27
  • 出版日期:
文章二维码